CompletedNCT00701532
Modafinil or placebo and brain responses in cocaine dependence
About this title
Brain Imaging Study of the Effects of Modafinil in Cocaine Addiction
Read the official source — NCT00701532Medication studyAges 18–65FranceAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Orsay and 1 more locationSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateApril 2009
- Recruitment status
- Completed
- Enrollment listed in the registry
- 29
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- France
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00701532
- Official title
Show the full official title
Dopamine Transporter (DAT) in Pharmacological Treatments of Cocaine Dependence. CAIMAN (Cocaine Addiction Imaging Medications and Neurotransmitters) Study
Get this study by email
Recruitment & locations
CompletedOrsay · Villejuif
Questions about this study
Who is behind this study?
The study sponsor is Assistance Publique - Hôpitaux de Paris.
Did this study involve medication?
Yes. The study involved medication, including Modafinil and PET (brain imaging) and placebo.
Who was this study for?
Listed age limits: 18 years to 65 years.
